The 24-mo Outcomes from the Noninferiority Randomised Controlled Trial of Surgery for Men with Urodynamic Stress Incontinence After Prostate Surgery (MASTER)
European Urology Focus · 2026-09 · 12 (4) · 636-643
DOI: 10.1016/j.euf.2026.07.012 ↗Kurz gefasst
Äquivalenzstudie in der Zeitschrift European Urology Focus, 2026-09. Verfasst von Lynda Constable und 13 weiteren Autor:innen. Beteiligte Einrichtung: Aberdeen Centre for Evaluation, University of Aberdeen, Aberdeen, UK. Electronic address: l.constable@abdn.ac.uk. Hauptthemen laut MEDLINE: Urinary Incontinence, Stress, Suburethral Slings, Prostatectomy, Postoperative Complications. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Health Technology Assessment Programme.
Themen: Inkontinenz
Abstract (Originalsprache)
BACKGROUND: The artificial urinary sphincter (AUS) is the most common surgical procedure for persistent stress urinary incontinence (SUI) after prostate surgery, whereas the male sling is a newer alternative. OBJECTIVE: To compare the 24-mo outcomes of the sling versus the AUS. DESIGN, SETTINGS, AND PARTICIPANTS: This was an unblinded, noninferiority randomised controlled trial including men from 27 UK urological centres with bothersome urodynamic SUI after prostate surgery. INTERVENTION: Men were randomised to receive a transobturator sling (n = 190) or an AUS (n = 190). Randomisation was minimised by type of surgery (radical prostatectomy/transurethral resection of the prostate), previous radiotherapy for prostate cancer (yes/no), and centre. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The primary outcome was self-reported continence (a composite outcome derived from two items in the validated International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form [ICIQ-UI SF]) at 12 mo after randomisation, with a noninferiority margin of 15%, via postal questionnaire. The secondary outcomes were self-reported continence, further treatments, patient-reported measures and serious adverse events up to 24 mo. RESULTS AND LIMITATIONS: A total of 380 participants were included. In terms of continence, the sling was noninferior to the AUS at 24 mo (estimated absolute risk difference in the intention-to-treat analysis, -0.006; 95% confidence interval [CI], -0.092 to 0.080; noninferiority p = 0.001), indicating lower success in the sling group, but with a CI excluding the noninferiority margin. Incontinence symptom scores (ICIQ-UI SF) decreased from 16.1 and 16.4 at baseline to 7.9 and 7.1 in the sling and AUS groups, respectively. The mean difference was 1.4 (95% CI, 0.2-2.6; p = 0.024). Secondary outcomes favoured the AUS over the sling. By 24 mo, more men underwent further surgery after receiving a sling (n = 20, 11%) than after receiving an AUS (n = 4, 2%). CONCLUSIONS: The 24-mo results confirm that the sling is noninferior to the AUS. Symptoms and quality of life significantly improved in both groups. Overall, secondary and post hoc analyses favour the AUS. PATIENT SUMMARY: Continence levels and symptoms improve with both surgeries. Most men are satisfied with their surgery, despite not being completely dry. Almost all other results show that men who have an artificial urinary sphincter have better outcomes than those who have a sling. Trial registration International Randomised Controlled Trial Registry, ISRCTN49212975. This trial was registered on July 22, 2013, and participants were randomised between January 29, 2014, and December 28, 2017.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Aberdeen Centre for Evaluation, University of Aberdeen, Aberdeen, UK. Electronic address: l.constable@abdn.ac.uk.
- Bristol Urological Institute, Southmead Hospital, North Bristol NHS Trust, Bristol, UK.
- Aberdeen Centre for Evaluation, University of Aberdeen, Aberdeen, UK.
- Aberdeen Centre for Evaluation, University of Aberdeen, Aberdeen, UK; Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
- Department of Urology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK; Translational and Clinical Research Institute, Newcastle University, Newcastle, UK.
- Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK.
Förderung
- Health Technology Assessment Programme
Zitieren
APA
Constable, L., Drake, M. J., Cooper, D., MacLennan, G., Harding, C., Mundy, A., McCormack, K., Norrie, J., Ramsay, C., Smith, R., Cotterill, N., Kilonzo, M., Abrams, P., & MASTER trial team (2026). The 24-mo Outcomes from the Noninferiority Randomised Controlled Trial of Surgery for Men with Urodynamic Stress Incontinence After Prostate Surgery (MASTER). European Urology Focus, 12(4), 636-643. https://doi.org/10.1016/j.euf.2026.07.012
Vancouver
Constable L, Drake MJ, Cooper D, MacLennan G, Harding C, Mundy A, et al. The 24-mo Outcomes from the Noninferiority Randomised Controlled Trial of Surgery for Men with Urodynamic Stress Incontinence After Prostate Surgery (MASTER). European Urology Focus. 2026;12(4):636-643. doi:10.1016/j.euf.2026.07.012
BibTeX
@article{Constable2026,
author = {Constable, Lynda and Drake, Marcus J and Cooper, David and MacLennan, Graeme and Harding, Chris and Mundy, Anthony and McCormack, Kirsty and Norrie, John and Ramsay, Craig and Smith, Rebecca and Cotterill, Nikki and Kilonzo, Mary and Abrams, Paul and MASTER trial team, MASTER trial team},
title = {The 24-mo Outcomes from the Noninferiority Randomised Controlled Trial of Surgery for Men with Urodynamic Stress Incontinence After Prostate Surgery (MASTER)},
journal = {European Urology Focus},
year = {2026},
volume = {12},
number = {4},
pages = {636--643},
doi = {10.1016/j.euf.2026.07.012}
}
EUVIMED